FDA NDC Directory · JSON-LD · Markdown

atovaquone

NDC 68462-421 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerGlenmark Pharmaceuticals Inc., USA
Marketing categoryAbbreviated NDA (generic) · App ANDA209685
Dosage form / routeSUSPENSION · ORAL
Active ingredientsATOVAQUONE (750 mg/5mL)
Marketing started20171231
Package count2

External sources

Source: openFDA. Public-domain (CC0).